Project Aim(s): Development of optimally informative biomarkers for ALS, and establishment of stakeholder agreement regarding their use. This will be achieved by defining, validating and harmonizing optimal methodologies that can be reliably implemented within a pan-European framework program.
Disease area
Field of research
Principal Investigator/ Researcher Names
Prof. Orla Hardiman
Institution
Start date
Project completed
Yes
Funding body
The EU Joint Programme – Neurodegenerative Disease Research (JPND) through The Health Research Board (HRB).
Grant Awarded (€)
232,000 (Consortium - €2,300,000)
Are you looking to Recruit Research Participants?
No
TCD was a work package leader for this project.